Description
Trocer 2.6 SR Tablet is a sustained-release formulation containing Glyceryl Trinitrate (also known as Nitroglycerin) as its active ingredient. Manufactured by Incepta Pharmaceuticals Ltd., this medication is primarily used for the long-term prophylactic management of angina pectoris due to coronary artery disease. The sustained-release mechanism ensures a gradual release of the active ingredient, providing prolonged therapeutic effects. Each tablet contains 2.6 mg of Nitroglycerin, which acts as a vasodilator, relaxing vascular smooth muscle and reducing the heart's workload. This helps alleviate chest pain associated with angina. The typical dosage is one tablet taken orally twice daily, preferably on an empty stomach, with a nitrate-free interval of 10–12 hours between doses. It's important to follow the prescribed dosage and consult a healthcare provider for any concerns or side effects
.jpg)
 400MG.jpg)
.jpg)
.jpg)
.jpeg)
.jpg)
.jpg)
.jpg)
 100 IU 3 ML.webp)
.webp)
.jpeg)
.jpeg)
.webp)
.png)
.webp)
.jpg)
.jpg)
.jpeg)
Change Language